H&K names Oestreicher to head U.S. pharma practice

Hill & Knowlton has named DeVries' Paul Oestreicher to head
its U.S. health and pharmaceutical practice.
Oestreicher, most recently head of the healthcare practice at DeVries,
previously led North American communications for Sanofi-Synthelabo and has served in various communications roles at Hoffmann-LaRoche, Wyeth and Edelman Public Relations.
He reports to U.S. chairman MaryLee Sachs.
Paul McDade, who previously headed Hill & Knowlton's worldwide healthcare practice, left the firm in March to work on a documentary film.


 

You must be a registered member of MMM to post a comment.

Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.

Email Newsletters